Anhui Huaren Health Pharmaceutical Co., Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Anhui Huaren Health Pharmaceutical Co., Ltd.

Why is Anhui Huaren Health Pharmaceutical Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 18.71% and Operating profit at 21.78% over the last 5 years

The company has declared Positive results for the last 4 consecutive quarters

OPERATING CASH FLOW(Y) Highest at CNY 783.68 MM
NET SALES(HY) At CNY 3,015.2 MM has Grown at 19.21%
ROCE(HY) Highest at 9.87%

With ROE of 12.75%, it has a fair valuation with a 1.64 Price to Book Value

Over the past year, while the stock has generated a return of 16.91%, its profits have risen by 68.3% ; the PEG ratio of the company is 0.2

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Anhui Huaren Health Pharmaceutical Co., Ltd. should be less than 10%
Overall Portfolio exposure to Retailing should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Retailing)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Anhui Huaren Health Pharmaceutical Co., Ltd. for you?

High Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Anhui Huaren Health Pharmaceutical Co., Ltd.

16.91%

0.38

69.45%

China Shanghai Composite

16.78%

1.20

13.96%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

18.71%

EBIT Growth (5y)

21.78%

EBIT to Interest (avg)

32.23

Debt to EBITDA (avg)

0.98

Net Debt to Equity (avg)

0.37

Sales to Capital Employed (avg)

1.17

Tax Ratio

25.02%

Dividend Payout Ratio

20.90%

Pledged Shares

Institutional Holding

ROCE (avg)

10.04%

ROE (avg)

7.94%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.64

EV to EBIT

11.79

EV to EBITDA

6.95

EV to Capital Employed

1.41

EV to Sales

0.85

PEG Ratio

0.19

Dividend Yield

ROCE (Latest)

12.00%

ROE (Latest)

12.75%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Bullish

RSI

Bearish

No Signal

Bollinger Bands

Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

18What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 783.68 MM

NET SALES(HY)

At CNY 3,015.2 MM has Grown at 19.21%

ROCE(HY)

Highest at 9.87%

RAW MATERIAL COST(Y)

Fallen by -8.21% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 9.24 times

NET PROFIT(Q)

Highest at CNY 79.34 MM

EPS(Q)

Highest at CNY 0.2

-11What is not working for the Company

INTEREST(HY)

At CNY 9.14 MM has Grown at 78.49%

INTEREST COVERAGE RATIO(Q)

Lowest at 2,739.54

OPERATING PROFIT(Q)

Lowest at CNY 114.27 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 8.04 %

Here's what is working for Anhui Huaren Health Pharmaceutical Co., Ltd.

Operating Cash Flow

Highest at CNY 783.68 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Net Sales

At CNY 3,015.2 MM has Grown at 19.21%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Net Profit

Highest at CNY 79.34 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 0.2

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Debtors Turnover Ratio

Highest at 9.24 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -8.21% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Anhui Huaren Health Pharmaceutical Co., Ltd.

Interest

At CNY 9.14 MM has Grown at 78.49%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest Coverage Ratio

Lowest at 2,739.54

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Operating Profit

Lowest at CNY 114.27 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 8.04 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales